Predicting Lung Injury From Transfusion in Patients With Liver Disease

Stopped early

Conditions studied: Transfusion-related Acute Lung Injury, Chronic Liver Disease, Gastrointestinal Bleeding

In brief

A certain molecule floating in the blood may represent a risk of lung injury after a transfusion. We are determining whether detection of this molecule on a simple blood clotting test will predict the development of lung injury due to transfusion in bleeding patients with chronic liver disease.

Key facts

Study ID

NCT01756690

Run by

University of Colorado, Denver

People needed

16

Starts

2011-10-01

Expected to finish

2016-12-01

Last updated by the study team

2017-01-30

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Colorado Denver, Anshutz medical campus — Aurora, Colorado, United States
• Denver Health and Hospital — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.